FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010538982> ?p ?o ?g. }

• W3010538982 endingPage "1169" @default.
• W3010538982 startingPage "1163" @default.
• W3010538982 abstract "Abstract Background A previous comparative study in Japan has demonstrated that the two consecutive UroVysion tests are useful tools to detect the presence of bladder cancer during follow-up after transurethral resection, but they also presented their high rates of false-positive results. Here, we aimed to evaluate the relationship between the UroVysion tests and subsequent intravesical recurrence. Methods In the previous study, patients without bladder cancer during the first analysis showed the same examination set repeated 3 months later as the second analysis. In this follow-up study, 326 patients showed negative findings confirmed on cystoscopy during the second UroVysion test. Recurrence-free survival was assessed using a median follow-up of 27 months. Results In the two consecutive UroVysion tests, 214 patients (65.6%) showed negative UroVysion results in both tests, whereas 91 presented a positive result on either tests and 21 patients presented positive results in both tests. During the follow-up, 40 patients (12.3%) had an intravesical recurrence with non-muscle-invasive bladder cancer. The recurrence rates in patients with negative results in both tests, those with one positive result in either tests, and those with positive results in both tests were 8.4%, 16.5%, and 33.3%, respectively. The multivariate analysis indicated that the history of bladder cancer and the consecutive UroVysion test pattern were independent risk factors for recurrence. Conclusions Our data confirmed the effectiveness of two consecutive UroVysion tests in predicting intravesical recurrence after TURBT. Further prospective studies would help determine an appropriate interval for cystoscopy follow-up." @default.
• W3010538982 created "2020-03-13" @default.
• W3010538982 creator A5005626530 @default.
• W3010538982 creator A5011851068 @default.
• W3010538982 creator A5015385547 @default.
• W3010538982 creator A5027874681 @default.
• W3010538982 creator A5032570626 @default.
• W3010538982 creator A5037097667 @default.
• W3010538982 creator A5038209360 @default.
• W3010538982 creator A5039725947 @default.
• W3010538982 creator A5039958599 @default.
• W3010538982 creator A5041954417 @default.
• W3010538982 creator A5047716545 @default.
• W3010538982 creator A5050249881 @default.
• W3010538982 creator A5051803042 @default.
• W3010538982 creator A5056810525 @default.
• W3010538982 creator A5056993350 @default.
• W3010538982 creator A5066389260 @default.
• W3010538982 creator A5068142343 @default.
• W3010538982 creator A5071455815 @default.
• W3010538982 date "2020-03-03" @default.
• W3010538982 modified "2023-10-01" @default.
• W3010538982 title "Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan" @default.
• W3010538982 cites W1938584611 @default.
• W3010538982 cites W1998384280 @default.
• W3010538982 cites W2021878203 @default.
• W3010538982 cites W2032659674 @default.
• W3010538982 cites W2089655266 @default.
• W3010538982 cites W2092289511 @default.
• W3010538982 cites W2810455471 @default.
• W3010538982 cites W2889646458 @default.
• W3010538982 cites W4297575310 @default.
• W3010538982 doi "https://doi.org/10.1007/s10147-020-01634-9" @default.
• W3010538982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7261273" @default.
• W3010538982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32125546" @default.
• W3010538982 hasPublicationYear "2020" @default.
• W3010538982 type Work @default.
• W3010538982 sameAs 3010538982 @default.
• W3010538982 citedByCount "10" @default.
• W3010538982 countsByYear W30105389822020 @default.
• W3010538982 countsByYear W30105389822021 @default.
• W3010538982 countsByYear W30105389822022 @default.
• W3010538982 countsByYear W30105389822023 @default.
• W3010538982 crossrefType "journal-article" @default.
• W3010538982 hasAuthorship W3010538982A5005626530 @default.
• W3010538982 hasAuthorship W3010538982A5011851068 @default.
• W3010538982 hasAuthorship W3010538982A5015385547 @default.
• W3010538982 hasAuthorship W3010538982A5027874681 @default.
• W3010538982 hasAuthorship W3010538982A5032570626 @default.
• W3010538982 hasAuthorship W3010538982A5037097667 @default.
• W3010538982 hasAuthorship W3010538982A5038209360 @default.
• W3010538982 hasAuthorship W3010538982A5039725947 @default.
• W3010538982 hasAuthorship W3010538982A5039958599 @default.
• W3010538982 hasAuthorship W3010538982A5041954417 @default.
• W3010538982 hasAuthorship W3010538982A5047716545 @default.
• W3010538982 hasAuthorship W3010538982A5050249881 @default.
• W3010538982 hasAuthorship W3010538982A5051803042 @default.
• W3010538982 hasAuthorship W3010538982A5056810525 @default.
• W3010538982 hasAuthorship W3010538982A5056993350 @default.
• W3010538982 hasAuthorship W3010538982A5066389260 @default.
• W3010538982 hasAuthorship W3010538982A5068142343 @default.
• W3010538982 hasAuthorship W3010538982A5071455815 @default.
• W3010538982 hasBestOaLocation W30105389821 @default.
• W3010538982 hasConcept C121608353 @default.
• W3010538982 hasConcept C126322002 @default.
• W3010538982 hasConcept C126894567 @default.
• W3010538982 hasConcept C188816634 @default.
• W3010538982 hasConcept C2778769751 @default.
• W3010538982 hasConcept C2780140570 @default.
• W3010538982 hasConcept C2780352672 @default.
• W3010538982 hasConcept C71924100 @default.
• W3010538982 hasConcept C77411442 @default.
• W3010538982 hasConceptScore W3010538982C121608353 @default.
• W3010538982 hasConceptScore W3010538982C126322002 @default.
• W3010538982 hasConceptScore W3010538982C126894567 @default.
• W3010538982 hasConceptScore W3010538982C188816634 @default.
• W3010538982 hasConceptScore W3010538982C2778769751 @default.
• W3010538982 hasConceptScore W3010538982C2780140570 @default.
• W3010538982 hasConceptScore W3010538982C2780352672 @default.
• W3010538982 hasConceptScore W3010538982C71924100 @default.
• W3010538982 hasConceptScore W3010538982C77411442 @default.
• W3010538982 hasIssue "6" @default.
• W3010538982 hasLocation W30105389821 @default.
• W3010538982 hasLocation W30105389822 @default.
• W3010538982 hasLocation W30105389823 @default.
• W3010538982 hasLocation W30105389824 @default.
• W3010538982 hasOpenAccess W3010538982 @default.
• W3010538982 hasPrimaryLocation W30105389821 @default.
• W3010538982 hasRelatedWork W1586830405 @default.
• W3010538982 hasRelatedWork W1976830962 @default.
• W3010538982 hasRelatedWork W2085161087 @default.
• W3010538982 hasRelatedWork W2120561004 @default.
• W3010538982 hasRelatedWork W2138050084 @default.
• W3010538982 hasRelatedWork W2370208313 @default.
• W3010538982 hasRelatedWork W2433727248 @default.
• W3010538982 hasRelatedWork W2623020188 @default.
• W3010538982 hasRelatedWork W324577642 @default.
• W3010538982 hasRelatedWork W2118673085 @default.

• next